Encompass Health director granted 4 RSUs

Hayes Cain A reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Hayes Cain A reported acquisition or exercise transactions in this Form 4 filing.

Encompass Health Corp reports that director Cain A. Hayes received a grant of 4 units of Encompass Health Common Stock on July 15, 2026. According to the award terms, these restricted stock units were credited as dividend equivalents following a $0.19 per-share dividend when the stock closed at $109.88. After this award, Hayes holds a total of 2,096 shares directly, reflecting routine, compensation-related accrual rather than an open-market purchase or sale.

Insider Trade Summary

Grant/Award: 4 shares

Grant/Award 1 txn

Insider Hayes Cain A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Encompass Health Common Stock F1	4	$0.00	$0.00

Holdings After Transaction: Encompass Health Common Stock — 2,096 shares (Direct)

Footnotes (1)

1. F1. Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $109.88. The transaction reported on this Form 4 is an award of RSUs as sociated with that dividend payment.

Key Figures

RSUs granted: 4.0000 units Dividend per share: $0.19 per share Closing price: $109.88 per share +2 more

5 metrics

RSUs granted 4.0000 units Grant to non-employee director on July 15, 2026

Dividend per share $0.19 per share Common stock dividend paid on July 15, 2026

Closing price $109.88 per share Closing price on the July 15, 2026 dividend payment date

Holdings after transaction 2096.0000 shares Total Encompass Health Common Stock reported following RSU-related grant

Transaction date July 15, 2026 Date of non-derivative grant/award acquisition

Key Terms

restricted stock units, non-employee director, dividend record date, closing price

4 terms

restricted stock units financial

"Additional restricted stock units are credited to each non-employee director's account"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

non-employee director financial

"Additional restricted stock units are credited to each non-employee director's account"

dividend record date financial

"RSUs in each director's account on the associated dividend record date and the per share dividend"

closing price financial

"divided by the closing price on the dividend payment date"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Encompass Health (EHC) report for Cain A. Hayes?

Encompass Health reported that director Cain A. Hayes received a grant of 4 restricted stock units on July 15, 2026. The award is tied to common stock dividend equivalents and is categorized as a grant or other acquisition, not an open-market trade.

How many Encompass Health (EHC) shares does Cain A. Hayes hold after this Form 4 transaction?

Following the reported transaction, Cain A. Hayes holds 2,096 shares of Encompass Health Common Stock directly. This total includes the 4 dividend-equivalent restricted stock units credited on July 15, 2026 under the company’s non-employee director award arrangements.

Was the Encompass Health (EHC) Form 4 transaction a market buy or sell?

No, the transaction was a grant/award acquisition of 4 restricted stock units, coded “A” on Form 4. It reflects compensation-related dividend equivalents for a non-employee director, not an open-market purchase or sale of Encompass Health shares.

How were the 4 RSUs for Encompass Health (EHC) director Cain A. Hayes calculated?

The 4 RSUs were credited pursuant to award agreements that add restricted stock units when dividends are paid. The number is based on existing RSUs, the $0.19 per-share dividend, and the $109.88 closing price on the July 15, 2026 dividend payment date.

What dividend did Encompass Health (EHC) pay in connection with this RSU award?

Encompass Health paid a $0.19 per-share dividend on its common stock on July 15, 2026. Under the director RSU agreements, this dividend triggered the crediting of additional dividend-equivalent restricted stock units, including the 4 units reported for Cain A. Hayes.

Does the Encompass Health (EHC) Form 4 indicate any remaining derivative positions for Cain A. Hayes?

The Form 4 data for Cain A. Hayes show no derivative transactions or remaining derivative positions in this report. The only activity disclosed is the non-derivative acquisition of 4 units of Encompass Health Common Stock tied to restricted stock unit awards.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/16/2026 - 04:10 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hayes Cain A

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM ALABAMA 35242

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	07/15/2026		A		4(1)	A	$0	2,096	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $109.88. The transaction reported on this Form 4 is an award of RSUs as sociated with that dividend payment.

	/s/ Patrick Darby, attorney-in-fact for Cain A. Hayes	07/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)